Anti-CD20 monoclonal antibodies have become central therapies for multiple sclerosis (MS) and other autoimmune disorders of the central nervous system, including neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), and autoimmune encephalitis. These ag...
D. Ferraro, G. Abbadessa, Federica Azzolini et al.· Neurological Therapeutics· 0 citations
ABSTRACT Objective Progression independent of relapse activity is a major determinant of long‐term disability in multiple sclerosis, but its immunopathologic basis remains incompletely understood. We investigated whether relapse‐independent progression in radiologically stable relapsing–remitting multiple sclerosis is...
Antonio Bruno, M. Conti, Ettore Dolcetti et al.· Annals of Clinical and Trans...· 0 citations
INTRODUCTION
Multiple sclerosis (MS) is a chronic and progressively disabling neurological disease associated with a substantial clinical and socioeconomic burden. The introduction of an increasing number of new innovative therapies has further intensified concerns regarding the long-term sustainability for the Italian...
Diego Centonze, Massimiliano Calabrese, E. Cocco et al.· Neurological Therapeutics· 0 citations
BACKGROUND
Idiopathic normal pressure hydrocephalus (iNPH) is associated with increased mortality and vascular-metabolic comorbidity, but prognostic biomarkers are lacking.
OBJECTIVES
To assess the triglycerides/high-density lipoprotein cholesterol (TG/HDL-C) ratio, an insulin resistance (IR) marker, and its associat...
Jacopo Bissacco, D. Mascioli, C. Simonetta et al.· Movement Disorders Clinical...· 0 citations
This strategy could improve the early detection of cognitive decline, guide personalised management, and ultimately enhance quality of life, while contributing to the long-term sustainability of healthcare systems in an ageing population, focusing on LOEU as a model for dementia prevention.
G. Bergamo, M. Fernandes, S. Maio et al.· Mechanisms of Ageing and Dev...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.